Pharming Group N.V. (PHAR)

Pharming Group Revenue

Pharming Group had revenue of $280.83M in the twelve months ending March 31, 2024, with 28.19% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $60.42M with 30.66% year-over-year growth. In the year 2023, Pharming Group had annual revenue of $272.57M with 24.61% growth.

• Revenue (ttm): $280.83M
• Revenue Growth: +28.19%
• P/S Ratio: 2.06
• Revenue / Employee: $735,150
• Employees: 382
• Market Cap: 577.28M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	272.57M	53.83M	24.61%
Dec 31, 2022	218.75M	-7.24M	-3.21%
Dec 31, 2021	225.99M	-32.76M	-12.66%
Dec 31, 2020	258.75M	45.95M	21.59%
Dec 31, 2019	212.80M	57.47M	37.00%
Dec 31, 2018	155.32M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.